0001677995-21-000002.txt : 20210525 0001677995-21-000002.hdr.sgml : 20210525 20210525130813 ACCESSION NUMBER: 0001677995-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210525 DATE AS OF CHANGE: 20210525 EFFECTIVENESS DATE: 20210525 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001677995 IRS NUMBER: 454872095 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-400573 FILM NUMBER: 21959125 BUSINESS ADDRESS: STREET 1: 846 STILL CREEK LANE CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 3019632400 MAIL ADDRESS: STREET 1: 846 STILL CREEK LANE CITY: GAITHERSBURG STATE: MD ZIP: 20878 D 1 primary_doc.xml X0708 D LIVE 0001677995 Cerium Pharmaceuticals, Inc. 312 Main Street Suite 200 GAITHERSBURG MD MARYLAND 20878 3019632400 DELAWARE None None Corporation true Gregg Lapointe 312 Main Street Suite 200 Gaithersburg MD MARYLAND 20878 Executive Officer Director Biotechnology Decline to Disclose 06b false 2021-03-26 false true false 25000 1905432 1905432 0 false 9 0 0 0 false Cerium Pharmaceuticals, Inc. /s/ Gregg Lapointe Gregg Lapointe Chief Executive Officer 2021-05-25